MARC details
| 000 -LEADER |
| fixed length control field |
01862nam a22002898i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20250918151248.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
120308s2011 flu b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781439810675 |
| Terms of availability |
RM409.12 |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
| Level of rules in bibliographic description |
201205021144 |
| Level of effort used to assign nonsubject heading access points |
zainol |
| y |
03-08-2012 |
| z |
yusri |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
UKM |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
WN415.W714r 2011 9 |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
WN415 |
| Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) |
.W714r 2011 9 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Williams, Lawrence E. |
| 245 10 - TITLE STATEMENT |
| Title |
Radiopharmaceuticals : |
| Remainder of title |
introduction to drug evaluation and dose estimation / |
| Statement of responsibility, etc. |
Lawrence E. Williams. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
| Place of publication, distribution, etc. |
Boca Raton : |
| Name of publisher, distributor, etc. |
CRC Press, |
| Date of publication, distribution, etc. |
2011. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xxi, 304 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
'This comprehensive overview details the process of radiopharmaceutical development, from cellular studies to animal experiments to the design and implementation of clinical trials. It examines the relative benefits of various radiopharmaceuticals and provides guidance on dose estimation and agent selection. Utilizing figures of merit for quantitative assessment, it covers standard medical internal radiation dose (MIRD), absorbed dose method for imaging agents, vivo methods for obtaining activity data, errors of activity estimation techniques, phantom-based and patient-based dose estimates and their associated uncertainties, and options available to clinical physicists. Supported by numerous examples from clinical trials, it discusses two and three dimensional estimation processes, including modern hybrid scanners such as SPECT /CT and PET/CT'--Provided by publisher. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Radiopharmaceuticals. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Clinical Trials as Topic. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Radiopharmaceuticals |
| General subdivision |
administration & dosage. |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
| a |
.b15263496 |
| b |
2021-05-28 |
| c |
2019-11-12 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Koha item type |
AM |
| Suppress in OPAC |
No |
| Call number prefix |
WN415.W714r 2011 9 |
| 914 ## - VTLS Number |
| VTLS Number |
vtls003489997 |
| 991 ## - LOCAL NOTE (NAMA FAKULTI/INSTITUT/PUSAT) |
| a |
Fakulti Farmasi, KKL. |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
| Library |
PERPUSTAKAAN DR ABDUL LATIFF |
| Operator's initials, OID (RLIN) |
2012-08-03 |
| Cataloger's initials, CIN (RLIN) |
m |
| Material Type (Sierra) |
Printed Books |
| Language |
English |
| Country |
|
| -- |
0 |
| -- |
.b15263496 |